SunCar Technology Group Inc (SDA) Stock News

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misuse of taxpayer funds. The allegations caused Ensign's stock to fall 8.15% on June 8, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

Rosen Law Firm is investigating potential securities claims on behalf of Elauwit Connection, Inc. (NASDAQ: ELWT) shareholders. The company filed an 8-K on February 27, 2026, announcing non-reliance on previously issued interim financial statements due to an error in network construction project revenue recognition during the first nine months of 2025. The disclosure resulted in a 6.8% stock price decline to $7.12 per share on March 2, 2026. The firm is preparing a class action lawsuit seeking recovery of investor losses.

Kessler Topaz Meltzer & Check, LLP is investigating potential securities law violations by Medline Inc. following significant FDA violations related to manufacturing quality standards and microbial contamination. The company's stock fell over 7% after the FDA warning letter and dropped an additional 12% following disappointing Q2 results and lowered full-year guidance.

A class action lawsuit has been filed against EquipmentShare.Com Inc on behalf of investors who purchased stock during its IPO in January 2026 or through June 2026. The lawsuit was triggered by a June 24, 2026 report alleging undisclosed related party transactions that netted EquipmentShare founders at least $77 million. Following the report, the company's stock price fell 6.62% on June 24 and declined an additional 11.7% the next trading day.

Kaplan Fox & Kilsheimer LLP has filed class action lawsuits against PROCEPT BioRobotics Corporation for allegedly using undisclosed discount programs that artificially inflated handpiece unit sales and revenues during the Class Period (February 28, 2024 - February 25, 2026). The firm is also pursuing cases against Hub Group, Inc. and investigating potential securities violations at Alignment Healthcare, Inc. Investors with losses are encouraged to contact the firm before respective deadlines.

Kaplan Fox has filed a class action lawsuit against Hub Group, Inc. (NASDAQ: HUBG) on behalf of investors who purchased securities between April 28, 2023 and May 11, 2026. The company disclosed a $77 million accounting error in February 2026 involving understatement of purchased transportation costs, followed by a May 2026 announcement of additional material misstatements in 2023 and 2024 financial statements. Hub Group stock fell significantly following both disclosures.

Grabar Law Office has filed federal securities fraud class action investigations against four companies: Erasca for misleading statements about its ERAS-0015 drug candidate and undisclosed patent risks; Insulet for defective manufacturing controls leading to voluntary product corrections; Power Solutions for overstating sales demand and understating manufacturing costs; and PROCEPT BioRobotics for using undisclosed discount programs that artificially inflated sales and created excess inventory. Shareholders who purchased shares during specified periods are eligible to seek damages and corporate reforms.

Hub Group (NASDAQ: HUBG) is facing a securities class action lawsuit for allegedly making false and misleading statements about its financial reporting, including premature revenue recognition and understatement of transportation costs. The company revealed in February 2026 that it had understated costs by $77 million and later disclosed that 2023 and 2024 financial reports were also materially misstated. These disclosures resulted in stock drops totaling over $870 million in market capitalization. Investors who purchased shares between April 28, 2023, and May 11, 2026, can seek lead plaintiff status by August 28, 2026.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of funds. Ensign's stock fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

A securities fraud class action lawsuit has been filed against Intuit Inc. (NASDAQ: INTU) for allegedly making materially false statements about its tax business strength and competitive advantages. The lawsuit covers the period from August 22, 2025 through May 20, 2026. Intuit's stock declined significantly after announcing a 17% workforce reduction and revealing weaker-than-expected TurboTax revenue growth of only 7% year-over-year, with the stock falling approximately 24% over two trading days.

A class action lawsuit has been filed against Photronics, Inc. for investors who purchased securities between December 10, 2025 and May 27, 2026. The company announced Q2 fiscal 2026 results on May 28, 2026 showing revenue and earnings below projections, with IC revenue declining 11% sequentially due to product launch delays and geopolitical uncertainty. Photronics stock fell more than 36% following the announcement. The lead plaintiff deadline is September 4, 2026.

Firefly Neuroscience announced a nearly four-fold increase in TMS center customer clinical assessments using its FDA-cleared Evoke AI-powered EEG/ERP platform. The platform combines quantitative EEG and event-related potentials to help clinicians assess brain activity and tailor treatments for psychiatric and behavioral health conditions. The company continues to expand adoption among TMS centers while building its proprietary database of over 200,000 EEG/ERP brain scans.

Rosen Law Firm is investigating potential securities claims on behalf of Elauwit Connection, Inc. (NASDAQ: ELWT) shareholders. On February 27, 2026, Elauwit announced it was restating previously issued interim financial statements due to an error in network construction project revenue recognition during the first nine months of 2025. The disclosure resulted in a 6.8% stock price decline. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of America's Car-Mart, Inc. (CRMT), Elauwit Connection, Inc. (ELWT), and PennyMac Financial Services, Inc. (PFSI) for allegedly issuing materially misleading business information. America's Car-Mart stock fell 18.2% on September 4, 2025, following the announcement of worse-than-expected first-quarter results with a loss of 69 cents per share compared to 15 cents per share in the prior year.

Law firm Kessler Topaz Meltzer & Check is investigating potential securities law violations by Innio N.V. after the company reported disappointing Q2 2026 financial results, including a $16.9 million net loss versus $62.4 million profit year-over-year. The poor results, attributed to $81.2 million in IPO-related one-off expenses, triggered a 17% stock price decline to $21.77 on July 29, 2026. The firm is encouraging affected investors to seek legal counsel.

Law firm Lowey Dannenberg is investigating Alignment Healthcare (ALHC) for potential federal securities violations following allegations by a former executive that the company manipulated finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The disclosure caused Alignment's stock to fall 16.7% on July 8, 2026.

Bernstein Liebhard LLP, an investor rights law firm, has announced investigations into potential breaches of fiduciary duty by directors and officers at AeroVironment, Capricor Therapeutics, and Calix. The firm is seeking to determine whether company leadership fulfilled obligations to shareholders and whether legal remedies may be available. Current shareholders are encouraged to contact the firm for consultation.

Grabar Law Office has launched investigations into potential securities fraud and fiduciary duty breaches at four major companies: Erasca (ERAS) for misleading statements about its ERAS-0015 drug candidate and undisclosed patent risks; Insulet (PODD) for defective manufacturing controls leading to voluntary product corrections; Power Solutions International (PSIX) for overstating sales demand and understating manufacturing costs; and PROCEPT BioRobotics (PRCT) for using undisclosed discount programs that artificially inflated sales figures and created excess inventory.

The Rosen Law Firm has announced an investigation into Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026, that the FBI seized certain domains associated with its subsidiary NetNut Ltd. Following this disclosure, Alarum's stock fell 51.49% on July 6, 2026. The firm is preparing a class action lawsuit to recover investor losses.

Hagens Berman is investigating Embecta Corp. for alleged securities law violations, claiming the company misrepresented the stability of its insulin pen needle business. On May 5, 2026, Embecta revealed significant revenue decline, slashed full-year EPS guidance by 43%, and cut its quarterly dividend by 93%, causing the stock to plummet 57.8% in a single trading day. The class action lawsuit covers the period from November 25, 2025 to May 4, 2026, with a lead plaintiff deadline of August 17, 2026.

Law firm Lowey Dannenberg is investigating EquipmentShare.com Inc. (NASDAQ: EQPT) for potential federal securities law violations following a short report alleging undisclosed related-party transactions worth at least $77 million to company founders. The investigation concerns whether the company provided accurate and complete information to investors. EquipmentShare's stock fell from $24.50 at IPO in January 2026 to $19.69 following the allegations in June 2026.

Hagens Berman has filed a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL) alleging the company misled investors about its NHS-Galleri cancer screening trial's design and efficacy. GRAIL failed to meet the trial's primary endpoint on February 19, 2026, causing the stock to plummet 50.55% and erasing $2.2 billion in market capitalization. The lead plaintiff deadline is August 4, 2026.

Dianthus Therapeutics granted equity awards to six newly-hired non-executive employees on August 3, 2026, consisting of non-qualified stock options to purchase 87,000 shares at an exercise price of $106.02 per share with a 10-year term. The grants were approved by the Compensation Committee as material inducements for employment.

The Rosen Law Firm is investigating potential securities claims against UP Fintech Holding Limited (TIGR) following a May 22, 2026 Reuters report about China's crackdown on cross-border securities trading. Chinese regulators announced penalties against online brokers including Tiger for illegally soliciting business without onshore licenses. UP Fintech's ADS fell 25.3% on the news, and the firm is preparing a class action lawsuit to recover investor losses.

Rosen Law Firm reminds GRAIL, Inc. investors who purchased stock between May 13, 2025 and February 19, 2026 of the August 4, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that GRAIL provided misleading statements about its NHS-Galleri trial results, concealing that the trial period was insufficient to demonstrate the primary endpoint of reducing Stage III-IV cancers.

Wolf Haldenstein has filed a securities fraud class action lawsuit against Hertz Global Holding for allegedly misleading investors about the company's financial condition. Hertz assured investors in May 2026 that its liquidity would sustain operations for at least twelve months, but just weeks later disclosed unexpected losses in the used car market and announced a dilutive $350-400 million debt offering. The stock price plummeted over 40% following the disclosure.

The Rosen Law Firm announced an investigation into potential securities claims against Alarum Technologies Ltd. (NASDAQ: ALAR) for allegedly issuing materially misleading business information. The investigation was triggered after Alarum disclosed on July 2, 2026, that the FBI seized domains associated with its subsidiary NetNut Ltd. The stock fell 51.49% on July 6, 2026, following the announcement. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm is investigating potential securities claims against Blaize Holdings, Inc. (NASDAQ: BZAI) following allegations of materially misleading business information. The investigation was triggered by a short seller report from Pelican Way Research alleging fraud in Blaize's $50 million NeoTensr deal, which caused the stock to fall 12% on April 28, 2026. The firm is preparing a class action lawsuit to recover investor losses.

Law firm Lowey Dannenberg is investigating EquipmentShare.com Inc. (NASDAQ: EQPT) for potential federal securities violations following a short report alleging undisclosed related-party transactions worth at least $77 million to company founders. The stock fell from $24.50 at IPO in January 2026 to $19.69 after the allegations were published in June 2026.

Grabar Law Office has initiated multiple shareholder investigations into alleged securities fraud and fiduciary duty breaches at EquipmentShare.com, Insulet Corporation, New Era Energy & Digital, and Planet Fitness. The investigations allege undisclosed related-party transactions, defective manufacturing controls, misleading statements about business progress, and false marketing claims that caused shareholders to purchase securities at artificially inflated prices.